ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - orlistat 120 mg - capsule, hard - 120 mg - orlistat 120 mg - orlistat

ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - orlistat 60 mg - capsule, hard - 60 mg - orlistat 60 mg - orlistat

ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - orlistat 60 mg - capsule, hard - 60 mg - orlistat 60 mg - orlistat

ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - orlistat 120 mg - capsule, hard - 120 mg - orlistat 120 mg - orlistat

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - orlistat, quantity: 120 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; sodium starch glycollate type a; hydrophobic colloidal silica anhydrous; microcrystalline cellulose; titanium dioxide; indigo carmine; sorbitan monolaurate; gelatin - prolistat is indicated for the treatment of obese patients with a body mass index (bmi) ? 30, and overweight patients with a bmi ? 27 in the presence of other risk factors, in conjunction with a mildly hypocaloric diet.

欧州連合 - 英語 - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - orlistat - obesity - antiobesity preparations, excl. diet products - alli is indicated for weight loss in adults who are overweight (body mass index, bmi, ≥ 28 kg/m2) and should be taken in conjunction with a mildly hypocaloric, lower-fat diet.

欧州連合 - 英語 - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - orlistat - obesity - antiobesity preparations, excl. diet products - xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (bmi) greater or equal to 30 kg/m2, or overweight patients (bmi > 28 kg/m2) with associated risk factors.treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5% of the body weight as measured at the start of therapy.

マルタ - 英語 - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - orlistat - hard capsule - orlistat 60 mg - antiobesity preparations, excl. diet products

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - orlistat 120mg;  ;   - capsule - 120 mg - active: orlistat 120mg     excipient: gelatin indigo carmine microcrystalline cellulose povidone purified talc sodium laurilsulfate sodium starch glycolate tekprint black sw-9008 titanium dioxide - xenical is for weight control, including weight loss, weight maintenance and prevention of weight regain in adults with an initial body mass index (bmi) of 30 or more. xenical should be used in conjunction with a low fat, calorie controlled diet.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

glaxosmithkline consumer healthcare australia pty ltd - orlistat -